Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients

NCT00401011 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma
Multiple Myeloma in Relapse

Interventions

DRUG: Perifosine
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

AEterna Zentaris